☆ 4.7 Editorial Material

Antidepressant potential of metabotropic glutamate receptor mGlu2 and mGlu3 negative allosteric modulators

NEUROPSYCHOPHARMACOLOGY (2019)

Get Full Text
Add to Collection

Journal

NEUROPSYCHOPHARMACOLOGY
Volume 44, Issue 1, Pages 214-215

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41386-018-0192-8

Keywords

-

Categories

Neurosciences Pharmacology & Pharmacy Psychiatry

Funding

  1. Pharmaceutical Research and Manufacturers of America Foundation
  2. National Institutes of Health (NIH) [R01MH062646, R37NS031373]
  3. NIH
  4. AstraZeneca
  5. Bristol-Myers Squibb
  6. Michael J. Fox Foundation
  7. Dystonia Medical Research Foundation
  8. CHDI Foundation
  9. Thome Memorial Foundation

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.